Biological network modeling identifies IPCS in Leishmania as a therapeutic target

Integrative Biology (United Kingdom)

Volumn 4, Issue 9, 2012, Pages 1130-1142

  Mandlik, Vineetha ^a   Shinde, Sonali ^a   Chaudhary, Ashish ^b   Singh, Shailza ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CERAMIDE; CERAMIDE DERIVATIVE; CERAMIDE GLUCOSYLTRANSFERASE; CERAMIDE KINASE; GLUCOSYLCERAMIDASE; INOSITOL PHOSPHORYLCERAMIDE SYNTHASE; MILTEFOSINE; NEW DRUG; PAROMOMYCIN; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDYLINOSITOL; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE ACYLTRANSFERASE; SYNTHETASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BIOLOGICAL MODEL; CONTROLLED STUDY; DISEASE CONTROL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME METABOLISM; GENE CONTROL; GENE SEQUENCE; HUMAN; HUMAN CELL; LEISHMANIA MAJOR; LEISHMANIASIS; LIPID METABOLISM; NETWORK LEARNING; NONHUMAN; OUTCOME ASSESSMENT; PHAGOLYSOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ALIGNMENT; SIMULATION; STOCHASTIC MODEL;

EID: 84870955411     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c2ib20037f     Document Type: Article

References (40)

1. D. B. Kell Systems biology, metabolic modeling and metabolomics in drug discovery and development Drug Discovery Today 2006 11 1085 1092
2. G. Singh K. G. Jayanarayan C. S. Dey Arsenite Resistance in Leishmania and Possible Drug Targets Adv. Exp. Med. Biol. 2008 625 1 8
3. M. J. Basu A. Mookerjee R. Banerjee M. Saha S. Singh K. Naskar G. Tripathy P. K. Sinha K. Pandey S. Sundar S. Bimal P. K. Das S. K. Choudhuri S. Roy Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection Antimicrob. Agents Chemother. 2008 52 1080 1093
4. S. Banerjee J. Ghosh S. Sen R. Guha R. Dhar M. Ghosh S. Datta B. Raychaudhury K. Naskar A. K. Haldar C. S. Lal K. Pandey V. N. Das P. Das S. Roy Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen presenting cells Infect. Immun. 2009 77 2330 2342
5. H. Sindermann L. S. Croft R. K. Engel W. Bommer H. Eibl C. Unger J. Engel Miltefosine (Impavido): the first oral treatment against leishmaniasis Med. Microbiol. Immunol. 2004 193 173 180
6. J. Soto J. Rea M. Valderrama J. Toledo L. Valda J. Ardiles J. Berman Efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia Am. J. Trop. Med. Hyg. 2009 81 3 387 389
7. S. Azzouz M. Maache M. F. Dos Santos M. E. Sarciron A. F. Petavy A. Osuna Aspects of the cytological activity of edelfosine, miltefosine, and ilmofosine in Leishmania donovani J. Parasitol. 2006 92 5 877 883
8. N. K. Verma C. S. Dey Possible mechanism of miltefosine-mediated death of Leishmania donovani Antimicrob. Agents Chemother. 2004 48 3010 3015
9. M. Rakotomanga M. Saint-Pierre-Chazalet P. M. Loiseau Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions Antimicrob. Agents Chemother. 2005 49 2677 2686
10. M. M. Nagiec E. E. Nagiec J. A. Baltisberger G. B. Wells R. L. Lester R. C. Dickson Sphingolipid synthesis as a target for antifungal drugs: Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene J. Biol. Chem. 1997 272 15 9809 9817
11. S. S. Sutterwala F. F. Hsu E. S. Sevova K. J. Schwartz K. Zhang P. Key J. Turk S. M. Beverley J. D. Bangs Developmentally regulated sphingolipid synthesis in African trypanosomes Mol. Microbiol. 2008 70 2 281 296
12. P. W. Denny H. Shams-Eldin H. P. Price D. F. Smith R. T. Schwarz The protozoan inositol phosphorylceramide synthase: a novel drug target that defines a new class of sphingolipid synthase J. Biol. Chem. 2006 281 38 28200 28209
13. K. Huitema J. Van-Den-Dikkenberg J. F. Brouwers J. C. Holthuis Identification of a family of animal sphingomyelin synthases EMBO J. 2004 23 33 44
14. T. Hashida-Okado A. Ogawa M. Endo R. Yasumoto K. Takesako I. Kato AUR1, a novel gene conferring aureobasidin resistance on Saccharomyces cerevisiae: a study of defective morphologies in Aur1p-depleted cells Mol. Gen. Genet. 1996 251 236 244
15. L. J. Heung C. Luberto M. Del Poeta Role of Sphingolipids in Microbial Pathogenesis Infect. Immun. 2006 74 28 39
16. K. Zhang J. M. Pompey F. F. Hsu K. Phillip P. Bandhuvula J. D. Saba J. Turk S. M. Beverley Redirection of sphingolipid metabolism towards de novo synthesis of ethanolamine in Leishmania EMBO J. 2007 26 1094 1104
17. G. Van Meer Q. Lisman Sphingolipid transport: rafts and translocators J. Biol. Chem. 2002 277 25855 25858
18. T. Kolter K. Sandhoff Recent advances in the biochemistry of sphingolipidoses Brain Pathol. 1998 8 1 79 100
19. M. Maceyka S. G. Payne S. Milstien S. Spiegel Sphingosine kinase, sphingosine-1-phosphate, and apoptosis Biochim. Biophys. Acta 2002 1585 193 201
20. S. Hakomori K. Handa Interaction of glycosphingolipids with signal transducers and membrane proteins in glycosphingolipid-enriched microdomains Methods Enzymol. 2003 363 191 207
21. P. P. Ruvolo Intracellular signal transduction pathways activated by ceramide and its metabolites Pharmacol. Res. 2003 47 5 383 392
22. K. Funato B. Vallée H. Riezman Biosynthesis and trafficking of sphingolipids in the yeast Saccharomyces cerevisiae Biochemistry 2002 41 51 15105 15114
23. K. Zhang F. F. Hsu D. A. Scott R. Docampo J. Turk S. M. Beverley Leishmania salvage and remodeling of host sphingolipids in amastigote survival and acidocalcisome biogenesis Mol. Microbiol. 2005 55 5 1566 1578
24. K. Zhang M. Showalter R. Javier F. F. Hsu J. Turk S. M. Beverley Sphingolipids are essential for differentiation but not growth in Leishmania EMBO J. 2003 22 6016 6026
25. P. P. Van Veldhoven S. Gijsbers G. P. Mannaerts J. R. Vermeesch V. Brys Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22(1) Biochim. Biophys. Acta 2000 1487 128 134
26. K. Zhang S. M. Beverley Phospholipid and Sphingolipid metabolism of Leishmania Mol. Biochem. Parasitol. 2009 170 55 64
27. J. D. Thompson D. G. Higgins T. J. Gibson SAM as a protein interaction domain involved in developmental regulation Nucleic Acids Res. 1994 22 22 4673 4680
28. J. Schultz C. P. Ponting K. Hofmann P. Bork SAM as a protein interaction domain involved in developmental regulation Protein Sci. 1997 6 1 249 253
29. D. Stapleton I. Balan T. Pawson F. Sicheri The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization Nat. Struct. Biol. 1999 6 1 44 49
30. J. H. Exton Phosphatidylcholine breakdown and signal transduction Biochim. Biophys. Acta 1994 1212 26 42
31. Y. Nishizuka The role of protein kinase C in cell surface signal transduction and tumour promotion Nature 1984 308 693 698
32. V. A. Sciorra A. J. Morris Roles for lipid phosphate phosphatases in regulation of cellular signaling Biochim. Biophys. Acta 2002 1582 45 51
33. D. N. Brindley Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids Biochim. Biophys. Acta 2002 1582 33 44
34. K. Ishikawa Y. Mihara K. Gondoh E. Suzuki Y. Asano X-ray structures of a novel acid phosphatase from Escherichia blattae and its complex with the transition-state analog molybdate EMBO J. 2000 19 2412 2423
35. M. G. Carman S. G. Han Roles of phosphatidate phosphatase enzymes in lipid metabolism Trends Biochem. Sci. 2006 31 694 699
36. D. Van der Spoel E. Lindahl B. Hess G. Groenhof A. E. Mark H. J. C. Berendsen Gromacs Fast and Flexible J. Comput. Chem. 2005 26 1701 1718
37. W. Humphrey A. Dalke K. Schulten VMD - Visual Molecular Dynamics J. Mol. Graphics 1996 14 33 38
38. M. Clamp J. Cuff S. M. Searle G. J. Barton The Jalview JAVA alignment editor Bioinformatics 2004 20 426 427
39. K. Tamura J. Dudley M. Nei S. Kumar MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0 Mol. Biol. Evol. 2007 24 1596 1599
40. Discovery Studio Modeling Environment, Release 3.0, San Diego, Accelrys Software Inc., 2007